Omega Therapeutics Ownership 2024 | Who Owns Omega Therapeutics Now?
Institutional Ownership
91.62%
Insider Ownership
1.62%
Retail Ownership
6.76%
Institutional Holders
68.00
Omega Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| FLAGSHIP PIONEERING INC. | 52.99% | 7.17% | 29,225,579 | - | - | 60,496,949 | Jun 30, 2024 |
| FMR LLC | 11.32% | 0.00% | 6,242,016 | -51,141 | -0.81% | 12,920,973 | Jun 30, 2024 |
| HARBOURVEST PARTNERS LLC | 6.37% | 3.87% | 3,512,110 | - | - | 7,270,068 | Jun 30, 2024 |
| STATE OF WISCONSIN INVESTMENT BOARD | 3.37% | 0.01% | 1,857,265 | - | - | 3,844,539 | Jun 30, 2024 |
| ARTAL GROUP S.A. | 2.40% | 0.07% | 1,323,530 | - | - | 2,739,707 | Jun 30, 2024 |
| VANGUARD GROUP INC | 2.02% | - | 1,114,731 | -165,194 | -12.91% | 2,307,493 | Jun 30, 2024 |
| BLUE OWL CAPITAL HOLDINGS LP | 1.91% | 0.61% | 1,055,882 | - | - | 2,185,676 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 1.37% | 0.00% | 754,223 | 427,078 | 130.55% | 1,561,242 | Jun 30, 2024 |
| 683 CAPITAL MANAGEMENT, LLC | 1.09% | 0.09% | 600,000 | 485,000 | 421.74% | 1,242,000 | Jun 30, 2024 |
| BLACKROCK INC. | 0.66% | - | 363,953 | -1,051,475 | -74.29% | 753,383 | Jun 30, 2024 |
| 72 INVESTMENT HOLDINGS, LLC | 0.64% | 1.84% | 352,941 | - | - | 730,588 | Jun 30, 2024 |
| PLATINUM INVESTMENT MANAGEMENT LTD | 0.63% | 0.03% | 346,352 | -540,430 | -60.94% | 716,949 | Jun 30, 2024 |
| STATE OF MICHIGAN RETIREMENT SYSTEM | 0.57% | 0.00% | 314,117 | - | - | 650,222 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.43% | - | 236,833 | -263,671 | -52.68% | 490,360 | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | 0.40% | 0.00% | 222,395 | 222,395 | 100.00% | 460,358 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.34% | 0.00% | 190,107 | 168,039 | 761.46% | 393,521 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.30% | 0.00% | 164,774 | -34,967 | -17.51% | 341,082,000 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.23% | 0.00% | 128,400 | 128,400 | 100.00% | 265,788 | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.22% | 0.01% | 119,000 | -25,000 | -17.36% | 246,330 | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | 0.21% | 0.00% | 116,009 | -13,380 | -10.34% | 240,138 | Jun 30, 2024 |
Omega Therapeutics's largest institutional shareholder is FLAGSHIP PIONEERING INC., holding 52.99% of the company's total share outstanding, currently valued at $60.50M. The top 10 institutional shareholders own together 83.50% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| FLAGSHIP PIONEERING INC. | 52.99% | 7.17% | 29,225,579 | - | - | 60,496,949 | Jun 30, 2024 |
| HARBOURVEST PARTNERS LLC | 6.37% | 3.87% | 3,512,110 | - | - | 7,270,068 | Jun 30, 2024 |
| 72 INVESTMENT HOLDINGS, LLC | 0.64% | 1.84% | 352,941 | - | - | 730,588 | Jun 30, 2024 |
| BLUE OWL CAPITAL HOLDINGS LP | 1.91% | 0.61% | 1,055,882 | - | - | 2,185,676 | Jun 30, 2024 |
| LONG CORRIDOR ASSET MANAGEMENT LTD | 0.15% | 0.17% | 85,000 | 85,000 | 100.00% | 175,950 | Jun 30, 2024 |
| 683 CAPITAL MANAGEMENT, LLC | 1.09% | 0.09% | 600,000 | 485,000 | 421.74% | 1,242,000 | Jun 30, 2024 |
| ARTAL GROUP S.A. | 2.40% | 0.07% | 1,323,530 | - | - | 2,739,707 | Jun 30, 2024 |
| GROUND SWELL CAPITAL, LLC | 0.03% | 0.03% | 19,170 | 19,170 | 100.00% | 39,682 | Jun 30, 2024 |
| PLATINUM INVESTMENT MANAGEMENT LTD | 0.63% | 0.03% | 346,352 | -540,430 | -60.94% | 716,949 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.15% | 0.01% | 83,939 | 83,939 | 100.00% | 173,754 | Jun 30, 2024 |
| MURPHY POHLAD ASSET MANAGEMENT LLC | 0.03% | 0.01% | 16,500 | - | - | 34,155 | Jun 30, 2024 |
| STATE OF WISCONSIN INVESTMENT BOARD | 3.37% | 0.01% | 1,857,265 | - | - | 3,844,539 | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | 0.14% | 0.01% | 77,417 | 77,417 | 100.00% | 160,253 | Jun 30, 2024 |
| RBF CAPITAL, LLC | 0.12% | 0.01% | 66,257 | - | - | 137,152 | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.22% | 0.01% | 119,000 | -25,000 | -17.36% | 246,330 | Jun 30, 2024 |
| STATE OF MICHIGAN RETIREMENT SYSTEM | 0.57% | 0.00% | 314,117 | - | - | 650,222 | Jun 30, 2024 |
| CERTUITY, LLC | 0.02% | 0.00% | 10,000 | 10,000 | 100.00% | 20,700 | Jun 30, 2024 |
| PALOMA PARTNERS MANAGEMENT CO | 0.05% | 0.00% | 27,700 | 27,700 | 100.00% | 57,339 | Jun 30, 2024 |
| CENTIVA CAPITAL, LP | 0.08% | 0.00% | 43,800 | 43,800 | 100.00% | 90,666 | Jun 30, 2024 |
| ALLSQUARE WEALTH MANAGEMENT LLC | 0.00% | 0.00% | 1,000 | - | - | 2,070 | Jun 30, 2024 |
The largest Omega Therapeutics shareholder by % of total assets is FLAGSHIP PIONEERING INC.. The company owns 29.23M shares of Omega Therapeutics (OMGA), representing 7.17% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| 683 CAPITAL MANAGEMENT, LLC | 1.09% | 0.09% | 600,000 | 485,000 | 421.74% | 1,242,000 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 1.37% | 0.00% | 754,223 | 427,078 | 130.55% | 1,561,242 | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | 0.40% | 0.00% | 222,395 | 222,395 | 100.00% | 460,358 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.34% | 0.00% | 190,107 | 168,039 | 761.46% | 393,521 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.23% | 0.00% | 128,400 | 128,400 | 100.00% | 265,788 | Jun 30, 2024 |
| LONG CORRIDOR ASSET MANAGEMENT LTD | 0.15% | 0.17% | 85,000 | 85,000 | 100.00% | 175,950 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.15% | 0.01% | 83,939 | 83,939 | 100.00% | 173,754 | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | 0.14% | 0.01% | 77,417 | 77,417 | 100.00% | 160,253 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.13% | 0.00% | 73,722 | 73,722 | 100.00% | 152,605 | Jun 30, 2024 |
| HRT FINANCIAL LP | 0.10% | 0.00% | 55,847 | 55,847 | 100.00% | 115,000 | Jun 30, 2024 |
| CENTIVA CAPITAL, LP | 0.08% | 0.00% | 43,800 | 43,800 | 100.00% | 90,666 | Jun 30, 2024 |
| RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC. | 0.07% | 0.00% | 38,167 | 38,167 | 100.00% | 79,006 | Jun 30, 2024 |
| PALOMA PARTNERS MANAGEMENT CO | 0.05% | 0.00% | 27,700 | 27,700 | 100.00% | 57,339 | Jun 30, 2024 |
| GROUND SWELL CAPITAL, LLC | 0.03% | 0.03% | 19,170 | 19,170 | 100.00% | 39,682 | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 0.06% | 0.00% | 31,617 | 13,873 | 78.18% | 65,448 | Jun 30, 2024 |
| ROYAL BANK OF CANADA | 0.03% | - | 14,334 | 13,529 | 1680.62% | 30,000 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.02% | 0.00% | 13,016 | 13,016 | 100.00% | 26,943 | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 0.02% | 0.00% | 11,700 | 11,700 | 100.00% | 24,219 | Jun 30, 2024 |
| CERTUITY, LLC | 0.02% | 0.00% | 10,000 | 10,000 | 100.00% | 20,700 | Jun 30, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | 0.02% | 0.00% | 12,019 | 6,884 | 134.06% | 24,879 | Jun 30, 2024 |
As of Jun 30 2024, Omega Therapeutics's largest institutional buyer is 683 CAPITAL MANAGEMENT, LLC. The company purchased 485.00K stocks of OMGA, valued at $1.24M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BLACKROCK INC. | 0.66% | - | 363,953 | -1,051,475 | -74.29% | 753,383 | Jun 30, 2024 |
| PLATINUM INVESTMENT MANAGEMENT LTD | 0.63% | 0.03% | 346,352 | -540,430 | -60.94% | 716,949 | Jun 30, 2024 |
| STATE STREET CORP | 0.17% | - | 94,730 | -386,847 | -80.33% | 196,091,000 | Jun 30, 2024 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | - | - | - | -279,464 | -100.00% | - | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.43% | - | 236,833 | -263,671 | -52.68% | 490,360 | Jun 30, 2024 |
| VANGUARD GROUP INC | 2.02% | - | 1,114,731 | -165,194 | -12.91% | 2,307,493 | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | - | - | - | -125,546 | -100.00% | - | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | - | - | - | -65,111 | -100.00% | - | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | - | - | - | -61,146 | -100.00% | - | Jun 30, 2024 |
| MARSHALL WACE, LLP | - | - | - | -59,547 | -100.00% | - | Jun 30, 2024 |
| FMR LLC | 11.32% | 0.00% | 6,242,016 | -51,141 | -0.81% | 12,920,973 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.30% | 0.00% | 164,774 | -34,967 | -17.51% | 341,082,000 | Jun 30, 2024 |
| MORGAN STANLEY | 0.17% | - | 93,999 | -34,564 | -26.88% | 194,577 | Jun 30, 2024 |
| UBS GROUP AG | 0.00% | - | 1,447 | -26,263 | -94.78% | 2,995 | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.22% | 0.01% | 119,000 | -25,000 | -17.36% | 246,330 | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | - | - | - | -23,649 | -100.00% | - | Jun 30, 2024 |
| RHUMBLINE ADVISERS | 0.01% | - | 2,915 | -19,424 | -86.95% | 6,033 | Jun 30, 2024 |
| BARCLAYS PLC | 0.02% | - | 13,457 | -17,016 | -55.84% | 27,000 | Jun 30, 2024 |
| HARBOR CAPITAL ADVISORS, INC. | - | - | - | -16,775 | -100.00% | - | Jun 30, 2024 |
| NEW YORK STATE COMMON RETIREMENT FUND | - | - | - | -14,082 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Omega Therapeutics's biggest institutional seller is BLACKROCK INC.. The company sold -1.05M shares of OMGA, valued at $753.38K.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| LONG CORRIDOR ASSET MANAGEMENT LTD | 0.15% | 0.17% | 85,000 | 85,000 | 100.00% | 175,950 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.15% | 0.01% | 83,939 | 83,939 | 100.00% | 173,754 | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | 0.14% | 0.01% | 77,417 | 77,417 | 100.00% | 160,253 | Jun 30, 2024 |
| HRT FINANCIAL LP | 0.10% | 0.00% | 55,847 | 55,847 | 100.00% | 115,000 | Jun 30, 2024 |
| CENTIVA CAPITAL, LP | 0.08% | 0.00% | 43,800 | 43,800 | 100.00% | 90,666 | Jun 30, 2024 |
| RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC. | 0.07% | 0.00% | 38,167 | 38,167 | 100.00% | 79,006 | Jun 30, 2024 |
| PALOMA PARTNERS MANAGEMENT CO | 0.05% | 0.00% | 27,700 | 27,700 | 100.00% | 57,339 | Jun 30, 2024 |
| GROUND SWELL CAPITAL, LLC | 0.03% | 0.03% | 19,170 | 19,170 | 100.00% | 39,682 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.02% | 0.00% | 13,016 | 13,016 | 100.00% | 26,943 | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 0.02% | 0.00% | 11,700 | 11,700 | 100.00% | 24,219 | Jun 30, 2024 |
| CERTUITY, LLC | 0.02% | 0.00% | 10,000 | 10,000 | 100.00% | 20,700 | Jun 30, 2024 |
| STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 0.00% | - | 2,000 | 2,000 | 100.00% | 4,140 | Jun 30, 2024 |
| MACQUARIE GROUP LTD | 0.00% | - | 1,227 | 1,227 | 100.00% | 2,540 | Jun 30, 2024 |
| GRADIENT INVESTMENTS LLC | 0.00% | - | 900 | 900 | 100.00% | 1,863 | Jun 30, 2024 |
| SRS CAPITAL ADVISORS, INC. | 0.00% | - | 54 | 54 | 100.00% | 112 | Jun 30, 2024 |
Omega Therapeutics's largest new institutional shareholder by number of shares is LONG CORRIDOR ASSET MANAGEMENT LTD, purchased 85.00K shares, valued at $175.95K, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| JACOBS LEVY EQUITY MANAGEMENT, INC | - | - | - | -279,464 | -100.00% | - | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | - | - | - | -125,546 | -100.00% | - | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | - | - | - | -65,111 | -100.00% | - | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | - | - | - | -61,146 | -100.00% | - | Jun 30, 2024 |
| MARSHALL WACE, LLP | - | - | - | -59,547 | -100.00% | - | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | - | - | - | -23,649 | -100.00% | - | Jun 30, 2024 |
| HARBOR CAPITAL ADVISORS, INC. | - | - | - | -16,775 | -100.00% | - | Jun 30, 2024 |
| NEW YORK STATE COMMON RETIREMENT FUND | - | - | - | -14,082 | -100.00% | - | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | - | - | - | -12,210 | -100.00% | - | Jun 30, 2024 |
| DEUTSCHE BANK AG\ | - | - | - | -12,207 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -12,011 | -100.00% | - | Jun 30, 2024 |
| AMERIPRISE FINANCIAL INC | - | - | - | -10,750 | -100.00% | - | Jun 30, 2024 |
| INVESCO LTD. | - | - | - | -10,708 | -100.00% | - | Jun 30, 2024 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | - | - | - | -10,530 | -100.00% | - | Jun 30, 2024 |
| LEGAL & GENERAL GROUP PLC | - | - | - | -2,971 | -100.00% | - | Jun 30, 2024 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | - | - | - | -2,450 | -100.00% | - | Jun 30, 2024 |
| AMERITAS INVESTMENT PARTNERS, INC. | - | - | - | -2,013 | -100.00% | - | Jun 30, 2024 |
| AMALGAMATED BANK | - | - | - | -822 | -100.00% | - | Jun 30, 2024 |
| SIMPLEX TRADING, LLC | - | - | - | -786 | -100.00% | - | Jun 30, 2024 |
| ZURCHER KANTONALBANK (ZURICH CANTONALBANK) | - | - | - | -299 | -100.00% | - | Jun 30, 2024 |
| RUSSELL INVESTMENTS GROUP, LTD. | - | - | - | -116 | -100.00% | - | Jun 30, 2024 |
| PNC FINANCIAL SERVICES GROUP, INC. | - | - | - | -49 | -100.00% | - | Jun 30, 2024 |
| FARTHER FINANCE ADVISORS, LLC | - | - | - | -38 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -9 | -100.00% | - | Jun 30, 2024 |
Omega Therapeutics's largest sold out institutional shareholder by shares sold is JACOBS LEVY EQUITY MANAGEMENT, INC, sold -0.28M shares, valued at -, as of undefined.
Omega Therapeutics Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| FIDELITY MT VERNON STREET TRUST | 0.11% | 3,213,508 | 413,145 | 14.75% | Feb 29, 2024 |
| BlackRock Health Sciences Trust | 0.08% | 20,226 | - | - | Mar 31, 2024 |
| BRIDGEWAY FUNDS INC | 0.06% | 144,000 | 144,000 | - | Mar 28, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.02% | 12,350 | - | - | Mar 31, 2024 |
| BlackRock Health Sciences Trust II | 0.02% | 55,871 | - | - | Mar 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.01% | 39,455 | - | - | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 3,788 | - | - | Mar 31, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.00% | 245,003 | -122,800 | -33.39% | Feb 29, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 1,088,966 | -516,406 | -32.17% | Mar 31, 2024 |
| VICTORY PORTFOLIOS | 0.00% | 71,720 | - | - | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 65,111 | - | - | Jan 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 216,935 | 16,800 | 8.39% | Feb 29, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 2,013 | - | - | Mar 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 17,625 | - | - | Mar 31, 2024 |
| Simplify Exchange Traded Funds | 0.00% | 27,859 | - | - | Mar 31, 2024 |
| BlackRock ETF Trust | 0.00% | 276 | - | - | Jan 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 9,830 | 3,681 | 59.86% | Mar 31, 2024 |
| Direxion Shares ETF Trust | 0.00% | 29,656 | - | - | Jan 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 511 | - | - | Mar 31, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 849 | - | - | Mar 31, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 15,827 | 3,602 | 29.46% | Feb 29, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 7,500 | - | - | Mar 31, 2024 |
| Goldman Sachs ETF Trust | 0.00% | 9,356 | -361 | -3.72% | Feb 29, 2024 |
| THRIVENT SERIES FUND INC | 0.00% | 10,299 | - | - | Mar 28, 2024 |
| NORTHERN FUNDS | 0.00% | 10,992 | -2,402 | -17.93% | Mar 28, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 1,500 | 301 | 25.10% | Mar 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 110,912 | 14,549 | 15.10% | Feb 29, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 222 | - | - | Dec 31, 2023 |
| iSHARES TRUST | 0.00% | 835,737 | 2,983 | 0.36% | Mar 31, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 2,577 | - | - | Feb 29, 2024 |
| EQ ADVISORS TRUST | 0.00% | 45,109 | - | - | Mar 31, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 1,000 | - | - | Mar 28, 2024 |
| VALIC Co I | 0.00% | 9,353 | -38 | -0.40% | Feb 29, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 378 | - | - | Mar 31, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 4,022 | -27 | -0.67% | Jan 31, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 110 | - | - | Dec 31, 2023 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 3,524 | - | - | Mar 31, 2024 |
| Guggenheim Active Allocation Fund | 0.00% | 116 | - | - | Feb 29, 2024 |
| ProFunds | 0.00% | 190 | -14 | -6.86% | Mar 31, 2024 |
| PROSHARES TRUST | 0.00% | 3,570 | -3,093 | -46.42% | Feb 29, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 15 | - | - | Dec 31, 2023 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 2,854 | 491 | 20.78% | Jan 31, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 12,172 | - | - | Mar 31, 2024 |
| TIAA-CREF FUNDS | 0.00% | 33,248 | - | - | Jan 31, 2024 |
| Brighthouse Funds Trust II | 0.00% | 8,737 | - | - | Mar 31, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 22,389 | - | - | Mar 31, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 819 | - | - | Feb 29, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 7,978 | - | - | Jan 31, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 2,761 | -11 | -0.40% | Jan 31, 2024 |
| J.P. Morgan Exchange-Traded Fund Trust | 0.00% | 2,309 | - | - | Jan 31, 2024 |
| Dimensional ETF Trust | 0.00% | 2,098 | - | - | Jan 31, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 10,437 | 3,910 | 59.91% | Mar 31, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 929 | - | - | Jan 31, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 12,041 | 1,113 | 10.18% | Mar 31, 2024 |
| ETF Series Solutions | 0.00% | 48 | - | - | Jan 31, 2024 |
| PACIFIC SELECT FUND | 0.00% | 7,620 | - | - | Mar 31, 2024 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 1,758 | - | - | Dec 31, 2023 |
| Bridge Builder Trust | 0.00% | 4,259 | - | - | Mar 31, 2024 |
| BlackRock Variable Series Funds, Inc. | 0.00% | 2,911 | - | - | Mar 31, 2024 |
| PRINCIPAL FUNDS, INC. | 0.00% | 3,065 | 187 | 6.50% | Jan 31, 2024 |
| BLACKROCK FUNDS | 0.00% | 2,235 | - | - | Jan 31, 2024 |
Omega Therapeutics's largest mutual fund holder by % of total assets is "FIDELITY MT VERNON STREET TRUST", owning 3.21M shares, compromising 0.11% of its total assets.
Omega Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 68 | -6.85% |
| 31 Mar, 24 | 73 | 12.31% |
| 31 Dec, 23 | 65 | 6.56% |
| 30 Sep, 23 | 61 | -1.61% |
| 30 Jun, 23 | 62 | 1.64% |
| 31 Mar, 23 | 61 | 12.96% |
| 31 Dec, 22 | 54 | 17.39% |
| 30 Sep, 22 | 46 | 2.22% |
| 30 Jun, 22 | 45 | -10.00% |
| 31 Mar, 22 | 50 | 11.11% |
| 31 Dec, 21 | 45 | 4.65% |
| 30 Sep, 21 | 43 | - |
As of 30 Jun 24, 68 institutions are holding Omega Therapeutics's shares, representing a decrease of -6.85% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 50,530,006 | -1.19% |
| 31 Mar, 24 | 51,136,580 | 1.80% |
| 31 Dec, 23 | 50,233,395 | -1.29% |
| 30 Sep, 23 | 50,889,925 | -0.40% |
| 30 Jun, 23 | 51,093,921 | 1.72% |
| 31 Mar, 23 | 50,232,227 | 17.72% |
| 31 Dec, 22 | 42,671,346 | 0.16% |
| 30 Sep, 22 | 42,605,171 | 0.29% |
| 30 Jun, 22 | 42,484,051 | -2.44% |
| 31 Mar, 22 | 43,545,915 | 2.53% |
| 31 Dec, 21 | 42,471,544 | 3.03% |
| 30 Sep, 21 | 41,221,408 | - |
Omega Therapeutics (OMGA) has 50.53M shares outstanding as of 30 Jun 24, down -1.19% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 91.62% | 1.02% |
| 31 Mar, 24 | 94.68% | 1.14% |
| 31 Dec, 23 | 91.10% | 1.07% |
| 30 Sep, 23 | 92.41% | 0.91% |
| 30 Jun, 23 | 100.92% | 1.03% |
| 31 Mar, 23 | 99.22% | 0.57% |
| 31 Dec, 22 | 132.09% | 1.67% |
| 30 Sep, 22 | 89.03% | 1.13% |
| 30 Jun, 22 | 88.79% | 1.07% |
| 31 Mar, 22 | 91.09% | 1.15% |
| 31 Dec, 21 | 88.89% | 0.55% |
| 30 Sep, 21 | 127.61% | - |
As of 30 Jun 24, Omega Therapeutics is held by 91.62% institutional shareholders, representing a 1.02% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 29 | -21.62% |
| 31 Mar, 24 | 37 | 23.33% |
| 31 Dec, 23 | 30 | 11.11% |
| 30 Sep, 23 | 27 | -18.18% |
| 30 Jun, 23 | 33 | -10.81% |
| 31 Mar, 23 | 37 | 76.19% |
| 31 Dec, 22 | 21 | 16.67% |
| 30 Sep, 22 | 18 | -14.29% |
| 30 Jun, 22 | 21 | -30.00% |
| 31 Mar, 22 | 30 | 20.00% |
| 31 Dec, 21 | 25 | -41.86% |
| 30 Sep, 21 | 43 | - |
29 institutional shareholders have increased their position in OMGA stock as of 30 Jun 24 compared to 37 in the previous quarter (a -21.62% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 21 | 50.00% |
| 31 Mar, 24 | 14 | -30.00% |
| 31 Dec, 23 | 20 | 42.86% |
| 30 Sep, 23 | 14 | - |
| 30 Jun, 23 | 14 | 100.00% |
| 31 Mar, 23 | 7 | -41.67% |
| 31 Dec, 22 | 12 | 20.00% |
| 30 Sep, 22 | 10 | -28.57% |
| 30 Jun, 22 | 14 | 55.56% |
| 31 Mar, 22 | 9 | 28.57% |
| 31 Dec, 21 | 7 | - |
| 30 Sep, 21 | - | - |
21 institutional shareholders have reduced their position in OMGA stock as of 30 Jun 24 compared to 14 in the previous quarter (a 50.00% increase).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 68 | -6.85% | 50,530,006 | -1.19% | 91.62% | 1.02% | 29 | -21.62% | 21 | 50.00% |
| 31 Mar, 24 | 73 | 12.31% | 51,136,580 | 1.80% | 94.68% | 1.14% | 37 | 23.33% | 14 | -30.00% |
| 31 Dec, 23 | 65 | 6.56% | 50,233,395 | -1.29% | 91.10% | 1.07% | 30 | 11.11% | 20 | 42.86% |
| 30 Sep, 23 | 61 | -1.61% | 50,889,925 | -0.40% | 92.41% | 0.91% | 27 | -18.18% | 14 | - |
| 30 Jun, 23 | 62 | 1.64% | 51,093,921 | 1.72% | 100.92% | 1.03% | 33 | -10.81% | 14 | 100.00% |
| 31 Mar, 23 | 61 | 12.96% | 50,232,227 | 17.72% | 99.22% | 0.57% | 37 | 76.19% | 7 | -41.67% |
| 31 Dec, 22 | 54 | 17.39% | 42,671,346 | 0.16% | 132.09% | 1.67% | 21 | 16.67% | 12 | 20.00% |
| 30 Sep, 22 | 46 | 2.22% | 42,605,171 | 0.29% | 89.03% | 1.13% | 18 | -14.29% | 10 | -28.57% |
| 30 Jun, 22 | 45 | -10.00% | 42,484,051 | -2.44% | 88.79% | 1.07% | 21 | -30.00% | 14 | 55.56% |
| 31 Mar, 22 | 50 | 11.11% | 43,545,915 | 2.53% | 91.09% | 1.15% | 30 | 20.00% | 9 | 28.57% |
| 31 Dec, 21 | 45 | 4.65% | 42,471,544 | 3.03% | 88.89% | 0.55% | 25 | -41.86% | 7 | - |
| 30 Sep, 21 | 43 | - | 41,221,408 | - | 127.61% | - | 43 | - | - | - |
Omega Therapeutics Insider Shareholders Trades
Open Market Insider Trades
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Omega Therapeutics's stock was made by Chan Barbara Y on May 31 2024, selling - shares at - per share (valued at -).
Omega Therapeutics Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | 9 | 8 | 112.50% |
| Q1 2024 | 8 | - | - |
| Q3 2023 | 2 | - | - |
| Q2 2023 | 7 | 3 | 233.33% |
| Q1 2023 | 8 | 2 | 400.00% |
| Q4 2022 | 6 | - | - |
| Q3 2022 | 2 | 1 | 200.00% |
| Q2 2022 | 13 | - | - |
| Q1 2022 | 7 | 1 | 700.00% |
| Q3 2021 | 17 | 13 | 130.77% |
9 total buy trades, and 8 total sell trades (buy/sell ratio of 1.13%) were made by Omega Therapeutics's insiders, as of Q2 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | - | - | - |
| Q1 2024 | - | - | - |
| Q3 2023 | - | - | - |
| Q2 2023 | - | 3 | - |
| Q1 2023 | 2 | 2 | 100.00% |
| Q4 2022 | - | - | - |
| Q3 2022 | - | 1 | - |
| Q2 2022 | - | - | - |
| Q1 2022 | - | - | - |
| Q3 2021 | 7 | - | - |
As of Q2 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Omega Therapeutics's stocks.
Omega Therapeutics Peer Ownership
| Ticker | Company |
|---|---|
| OLMA | Olema Pharmaceuticals, Inc. |
| PMVP | PMV Pharmaceuticals, Inc. |
| CNTA | Centessa Pharmaceuticals plc |
| LRMR | Larimar Therapeutics, Inc. |
| MLYS | Mineralys Therapeutics, Inc. |
| CVKD | Cadrenal Therapeutics, Inc. Common Stock |
| AVTE | Aerovate Therapeutics, Inc. |
| OBIO | Orchestra BioMed Holdings, Inc. |
| MLTX | MoonLake Immunotherapeutics |
| MNOV | MediciNova, Inc. |
| PHVS | Pharvaris N.V. |
| GPCR | Structure Therapeutics Inc. |
| PEPG | PepGen Inc. |
| NVCT | Nuvectis Pharma, Inc. |
| CMPX | Compass Therapeutics, Inc. |
| ELVN | Enliven Therapeutics, Inc. |
| ELYM | Eliem Therapeutics, Inc. |
OMGA Ownership FAQ
Who Owns Omega Therapeutics?
Omega Therapeutics is owned by institutional shareholders (91.62%), insiders (1.62%), and public (6.76%). The largest institutional shareholder of Omega Therapeutics is FLAGSHIP PIONEERING INC. (52.99% of total shares) and the top mutual fund owner is FIDELITY MT VERNON STREET TRUST (0.11% of total shares).
Who are the major institutional shareholders of Omega Therapeutics?
Omega Therapeutics's major institutional shareholders are FLAGSHIP PIONEERING INC., FMR LLC, HARBOURVEST PARTNERS LLC, STATE OF WISCONSIN INVESTMENT BOARD, and ARTAL GROUP S.A.. The top five shareholders own together 76.45% of the company's share outstanding.
How many Omega Therapeutics shareholders are there?
As of Jun 2024, there are 68 institutional shareholders of Omega Therapeutics.
What percentage of Omega Therapeutics is owned by FLAGSHIP PIONEERING INC?
FLAGSHIP PIONEERING INC owns 29.23M shares of Omega Therapeutics, representing 52.99% of the company's total shares outstanding, valued at $60.5M (as of Jun 2024).
What percentage of Omega Therapeutics is owned by FMR LLC?
As of Jun 2024, FMR LLC holds 6.24M shares of Omega Therapeutics (OMGA), compromising 11.32% of the company, valued at $12.92M.
What percentage of Omega Therapeutics is owned by HARBOURVEST PARTNERS LLC?
HARBOURVEST PARTNERS LLC is the third largest holder of Omega Therapeutics. The company owns 3.51M of the company's shares outstanding (worth $7.27M).